Be in the know. 5 key reads for Thursday…

  1. Tesla Stock Waffles On Earnings, Another Executive Departure (Investor’s Business Daily)
  2. Intel Slumps as Wall Street Scrutinizes New CEO Swan’s Pedigree (Bloomberg)
  3. Pelosi: ‘There’s Not Going to Be Any Wall Money’ (CNS News)
  4. Trump Today: President conditions China trade deal on opening up markets to U.S. farm, manufactured goods (Market Watch)
  5. The Threat of a Eurozone Recession (Project Syndicate)

If you found this post helpful, please consider visiting a few of our sponsors who have offers that may be relevant to you.

Insider Buying

Director Michael Schmertzler purchased $1,999,995 (66,225 shares) of PTC Therapeutics, inc. PTCT stock through his fund Sections Six Partners, LP on 1/25/2019.  The stock was down ~40% off of its Oct 1 peak at purchase.

If you found this post helpful, consider visiting a few of our sponsors who have offers that may be relevant to you.

Be in the know. 5 key reads for Wednesday…

  1. Boeing Sales Top $100 Billion for First Time (Bloomberg)
  2. ‘Bad news is over’ — here’s what every major analyst says about Apple’s earnings (CNBC)
  3. Powell to Stress Fed Patience on Rate Hikes: Decision Day Guide (Bloomberg)
  4. A New Round of Trade Talks Could Be Just Enough to Keep Markets Calm (Barron’s)
  5. Roomba Maker iRobot Expands Fleet With Terra Lawn-Mowing Bot (Investor’s Business Daily)

If you found this post helpful, please consider visiting a few of our sponsors who have offers that may be relevant to you.

Insider Buying

Yesterday 1/28/19, Francis Blake – a Director of DAL (Delta Airlines) – purchased 5,185 shares of stock at $48.17 for a total out of pocket purchase of $249,743.

If you found this post helpful, please consider visiting a few of our sponsors who have offers that may be relevant to you.

Be in the know. 5 key reads for Tuesday…

  1. In Unloved Dell, Investors Can Find a Silver Lining in Its VMware Stake (Barron’s)
  2. Apple iPhone outlook has nowhere to go but up: analyst (New York Post)
  3. A $4 Trillion Scapegoat for Market Volatility: the Fed’s Shrinking Portfolio (Wall Street Journal)
  4. Biogen (BIIB) Tops Q4 EPS by 25c, Offers Guidance (Street Insider)
  5. Experts are throwing cold water on a ‘housing collapse’ (ITB) (Business Insider)

If you found this post helpful, please consider visiting a few of our sponsors who have offers that may be relevant to you.